Dr. Daniel M. Anderson
Claim this profileAbbott-Northwestern Hospital
Area of expertise
Cancer
Daniel M. Anderson has run 14 trials for Cancer. Some of their research focus areas include:
Lung Cancer
Daniel M. Anderson has run 12 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Abbott Northwestern Hospital
Regions Hospital
Clinical Trials Daniel M. Anderson is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting
2 awards
Phase 3
2 criteria
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting
1 award
Phase 2
10 criteria
More about Daniel M. Anderson
Clinical Trial Related
7 years of experience running clinical trials · Led 61 trials as a Principal Investigator · 17 Active Clinical Trials
Treatments Daniel M. Anderson has experience with
- Nivolumab
- Pembrolizumab
- Carboplatin
- Biospecimen Collection
- Paclitaxel
- Cabozantinib S-malate
Breakdown of trials Daniel M. Anderson has run
Cancer
Lung Cancer
Breast Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel M. Anderson specialize in?
Daniel M. Anderson focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Daniel M. Anderson currently recruiting for clinical trials?
Yes, Daniel M. Anderson is currently recruiting for 17 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Daniel M. Anderson has studied deeply?
Yes, Daniel M. Anderson has studied treatments such as Nivolumab, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Daniel M. Anderson?
Apply for one of the trials that Daniel M. Anderson is conducting.
What is the office address of Daniel M. Anderson?
The office of Daniel M. Anderson is located at: Abbott-Northwestern Hospital, Minneapolis, Minnesota 55407 United States. This is the address for their practice at the Abbott-Northwestern Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.